Renovaro Biosciences Stock Analysis

Renovaro Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Renovaro Biosciences recorded a loss per share of 0.8. The entity had not issued any dividends in recent years. To find out more about Renovaro Biosciences contact Mark MD at 305 918 1980 or learn more at https://renovarobio.com.

Renovaro Biosciences Investment Alerts

Renovaro Biosciences Upcoming and Recent Events

Renovaro Stock Institutional Investors

Note, although Renovaro Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Renovaro Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 67.79 M.

Renovaro Profitablity

Management Efficiency

Renovaro Biosciences has return on total asset (ROA) of (0.1202) % which means that it has lost $0.1202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8788) %, meaning that it created substantial loss on money invested by shareholders. Renovaro Biosciences' management efficiency ratios could be used to measure how well Renovaro Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -20.33. The current year's Return On Capital Employed is expected to grow to -0.58. The current year's Other Current Assets is expected to grow to about 1.9 M, whereas Total Assets are forecasted to decline to about 88.6 M.

Technical Drivers

As of the 11th of October 2024, Renovaro Biosciences holds the Coefficient Of Variation of (620.62), risk adjusted performance of (0.12), and Variance of 77.53. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Renovaro Biosciences, as well as the relationship between them.

Renovaro Biosciences Price Movement Analysis

Renovaro Biosciences Insider Trading Activities

Renovaro Biosciences Outstanding Bonds

Renovaro Biosciences Predictive Daily Indicators

Renovaro Biosciences Forecast Models

Renovaro Biosciences' time-series forecasting models are one of many Renovaro Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Renovaro Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Renovaro Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Renovaro shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Renovaro Biosciences. By using and applying Renovaro Stock analysis, traders can create a robust methodology for identifying Renovaro entry and exit points for their positions.

When running Renovaro Biosciences' price analysis, check to measure Renovaro Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renovaro Biosciences is operating at the current time. Most of Renovaro Biosciences' value examination focuses on studying past and present price action to predict the probability of Renovaro Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renovaro Biosciences' price. Additionally, you may evaluate how the addition of Renovaro Biosciences to your portfolios can decrease your overall portfolio volatility.